Pre-market Hot Trades in US Stocks

InMed Pharmaceuticals is down 15.63% in pre-market trading. Based on recent key news:

1. On May 19, InMed Pharmaceuticals announced a merger with Mentari Therapeutics to advance migraine prevention therapies. After the merger, InMed shareholders are expected to own approximately 1.51% of the merged company, which is expected to have an equity value of about $421.4 million. This news has led to stock price fluctuations.

2. On May 19, InMed Pharmaceuticals modified its preferred investment option with Armistice Capital Master Fund Ltd., lowering the exercise price from $16.60 to $0.80 per share, and granting the fund the right to subscribe for up to 278,761 common shares. This move provides investors with a more favorable entry point, impacting the stock price.

3. On May 19, the main assets of Mentari Therapeutics, MT-001 and MT-002, were found to have significant therapeutic potential, aiming to expand the migraine prevention market through a subcutaneous delivery mechanism combining anti-CGRP and anti-PACAP mechanisms. This news has attracted market attention, affecting the stock price. The equity value of the merged company is approximately $421.4 million.

SunCar Tech is down 11.46% in pre-market trading. Based on recent news:

1. On May 18, SunCar Technology Group Inc. forecasted net revenue of $1 million for the first quarter of 2026, marking its third consecutive profitable quarter. Despite a 25% year-over-year revenue growth, the market expected revenue of $132.5 million, and the shortfall led to a decline in stock price.

2. On May 18, the financial report released by SunCar Technology Group Inc. indicated that revenue for the first quarter of 2026 is expected to be $128 million, a significant improvement compared to a loss of $3.6 million in the first quarter of 2025. However, the market still has doubts about its profitability, putting pressure on the stock price.

3. On May 18, SunCar Technology Group Inc.'s earnings forecast failed to meet market expectations. Although the company has been profitable for three consecutive quarters, the market lacks confidence in its future growth, leading to a significant drop in stock price. Doubts about profitability have pressured the stock price.

Top Gainers in Pre-market US Stocks

Micware is up 381.20% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no_news Silexion pre-market rose 197.51%. Based on recent key news:

1. On May 20, Silexion Therapeutics announced the exercise of warrants, resulting in total proceeds of $1 million. This news significantly boosted the stock price, with investors optimistic about the company's future liquidity and growth prospects. The biotechnology industry has been quite volatile recently.

GCL Global pre-market rose 85.29%. Based on recent key news:

1. On May 19, GCL Global announced a strategic investment from ADATA Technology to accelerate global entertainment and digital growth. This news led to a substantial increase in the stock price, with an investment amount of $10 million. Source: Reuters

2. On May 19, GCL Global released relevant information through the EDGAR system, further confirming the investment details and enhancing market confidence. Source: Public Technologies

3. On May 20, Benzinga's stock ranking indicated that GCL maintained a negative price trend in the short, medium, and long term; nevertheless, the positive response from investors to the new investment drove the stock price up. Source: Benzinga The market remains focused on investments in the entertainment and digital sectors